SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 20th, 2009 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 19, 2009, between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT REXAHN PHARMACEUTICALS, INC.Common Stock Purchase Warrant • October 20th, 2009 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock; provided, however, that the period set forth above as the Termination Date shall be extended for the number of days during such period in which (i) trading in the Common Stock is suspended by any Trading Market, or (ii) the Registration Statement is not effective but in no event later than April 19, 2010. The purchase price of one share of Common Stock under this Warrant shall be equal to
STRICTLY CONFIDENTIAL Mr. Tae Heum (Ted) Jeong Sr. Vice President of Finance Chief Financial Officer Rexahn Pharmaceuticals, Inc.Placement Agent Agreement • October 20th, 2009 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
